Clinical Trial Update: A Study in Participants With Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 study in participants with diabetic kidney disease was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathy

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Kidney Disease, Diabetic Nephropathy | Phase 2 | Status: TERMINATED | Results posted: 2017-12-13